Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Feb 15;29(1):011001.
doi: 10.11613/BM.2019.011001. Epub 2018 Dec 15.

Falsely prolonged activated partial thromboplastin time - a pre- and post-analytical issue

Affiliations
Case Reports

Falsely prolonged activated partial thromboplastin time - a pre- and post-analytical issue

Charlotte Gils et al. Biochem Med (Zagreb). .

Abstract

This case highlights two common pre-analytical problems identified in routine coagulation testing of activated partial thromboplastin time (aPTT), which were overlooked because of a concurrent flag code indicating no coagulation and the result was replaced by asterisks. It concerns a boy with gastrointestinal bleeding and prolonged aPTT > 300 seconds, which raised the suspicion of haemophilia. When all other coagulation parameters (including specific coagulation factors VIII and IX) turned out to be normal, aPTT was re-measured using another analysis principle, which revealed a normal aPTT. The primary aPTT result turned out to be aborted due to concurrent haemolysis and lipaemia, but was erroneously interpreted as prolonged coagulation. The lesson is awareness of the possibility of numerous flag codes on the same sample overruling each other, and awareness on the responsibility in the post-analytical phase that must be carried by increased educational focus and by the manufacturers.

Keywords: activated partial thromboplastin time; haemolysis; lipemia; post-analytical errors; pre-analytical errors.

PubMed Disclaimer

Conflict of interest statement

Potential conflict of interest: None declared.

Figures

Figure 1
Figure 1
The aPTT measurement curve in the patient sample. X-axis: time (s), Y-axis: aPTT-value (s). aPTT - activated partial thromboplastin time.
Figure 2
Figure 2
A normal aPTT measurement curve. aPTT - activated partial thromboplastin time.

Similar articles

Cited by

References

    1. Lippi G, Plebani M, Favaloro JE. Interference in Coagulation Testing: Focus on Spurious Hemolysis, Icterus, and Lipemia. Semin Thromb Hemost. 2013;39:258–66. - PubMed
    1. Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med. 2008;46:764–72. 10.1515/CCLM.2008.170 - DOI - PubMed
    1. Clinical and Laboratory Standards Institute (CLSI). Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays. Approved Guideline - Fifth edition. CLSI document H21-A5. Wayne, USA: CLSI, 2008.
    1. Falay M, Senes M, Yücel D, Turhan T, Dagdas S, Pekin M, et al. What should be the laboratory approach against isolated prolonged activated partial thromboplastin time? J Clin Lab Anal. 2018;e22415:•••.; epub ahead of print 10.1002/jcla.22415 - DOI - PMC - PubMed
    1. Geens T, Vertessen F, Malfait R, Deiteren K, Maes MB. Validation of the Sysmex CS5100 coagulation analyzer and comparison to the Stago STA-R analyzer for routine coagulation parameters. Int J Lab Hematol. 2015;37:372–81. 10.1111/ijlh.12295 - DOI - PubMed

Publication types